MODD net incomeQ1 2027-$6.49M
MODD net income was -$6.49M in fiscal Q1 2027 (ended Jun 30, 2026), compared with -$6.70M a year earlier. For the full fiscal 2026 it was -$28.24M, compared with -$18.82M in fiscal 2025.
Modular Medical Inc. (MODD) financials
For the twelve months ended Jun 30, 2026, Modular Medical Inc. reported -$28.03M of net income.
- Net income, TTM
- -$28.03M
- Free cash flow, TTM
- -$28.04M
- Cash
- $3.92M
- Market cap
- $12.6M
FY2015FY2018
FY2015FY2026
FY2018FY2026
MODD revenue and earnings growth
MODD EPSQ1 2027-$1.19
MODD diluted EPS was -$1.19 in fiscal Q1 2027 (ended Jun 30, 2026). For the full fiscal 2026 it was -$12.36.
MODD free cash flowQ1 2027-$6.66M
MODD free cash flow was -$6.66M in fiscal Q1 2027 (ended Jun 30, 2026), compared with -$6.31M a year earlier. For the full fiscal 2026 it was -$27.68M, compared with -$18.21M in fiscal 2025.
Income statement
| Line item | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Jun 30, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | $0 | $0 |
| Cost of revenue | - | - | - | - | - | - | - | - | - | $0 |
| Gross profit | - | - | - | - | - | - | - | - | - | $0 |
| Research and development | $19.97M | $14.70M | $12.88M | $9.06M | $7.73M | $4.08M | $3.03M | $1.88M | $332.6K | - |
| Selling, general and admin | $7.59M | $4.35M | $4.65M | $4.82M | $7.20M | $3.25M | $2.31M | $695.0K | $98.7K | $16.1K |
| Operating income | -$27.56M | -$19.05M | -$17.53M | -$13.88M | -$14.93M | -$7.34M | -$5.35M | -$2.58M | -$666.2K | -$16.1K |
| Interest expense | - | - | - | - | $2.75M | $39.8K | $0 | - | - | - |
| Pre-tax income | -$28.24M | -$18.82M | -$17.47M | -$13.88M | -$18.63M | -$7.38M | -$5.32M | -$2.54M | -$657.6K | -$31.0K |
| Income tax | $2.0K | $2.0K | $2.0K | $2.0K | $1.6K | $1.6K | $1.6K | $1.6K | $1.6K | $0 |
| Net income | -$28.24M | -$18.82M | -$17.47M | -$13.88M | -$18.63M | -$7.38M | -$5.32M | -$2.54M | -$659.2K | -$31.0K |
| EPS, basic | -$12.36 | -$15.26 | -$23.40 | -$34.50 | -$82.20 | -$36.00 | -$27.00 | -$13.50 | -$4.41 | -$1.80 |
| EPS, diluted | -$12.36 | -$15.26 | -$23.40 | -$34.50 | -$82.20 | -$36.00 | -$27.00 | -$13.50 | -$4.41 | -$1.80 |
| Diluted shares | 2.3M | 1.2M | 745,900 | 403,433.333 | 226,923.667 | 207,052.067 | 198,497.433 | 184,329.256 | 148,181.211 | 13,886.844 |
Balance sheet
| Line item | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Jun 30, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $6.94M | $13.10M | $9.23M | $3.80M | $9.08M | $1.47M | $3.12M | $6.55M | $4.30M | $0 |
| Receivables | - | - | $142.0K | - | - | - | - | - | - | - |
| Current assets | $7.54M | $13.52M | $9.70M | $4.05M | $9.39M | $1.65M | $3.19M | $6.57M | $4.31M | $2.5K |
| Total assets | $14.83M | $18.73M | $13.81M | $7.25M | $9.85M | $2.25M | $3.86M | $6.65M | $4.33M | $2.5K |
| Current liabilities | $1.87M | $1.26M | $1.46M | $979.0K | $969.7K | $3.30M | $661.4K | $178.9K | $15.5K | $165.2K |
| Total liabilities | $1.87M | $1.66M | $2.27M | $2.17M | $1.01M | $3.52M | $980.1K | $178.7K | $15.5K | $165.2K |
| Shareholders' equity | $12.96M | $17.08M | $11.54M | $5.08M | $8.84M | -$1.28M | $2.88M | $6.47M | $4.32M | -$162.7K |
Cash flow
| Line item | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Jun 30, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$23.75M | -$15.72M | -$13.95M | -$11.01M | -$10.26M | -$5.91M | -$4.09M | -$1.81M | -$791.1K | $0 |
| Capital expenditures | $3.93M | $2.49M | $1.70M | $1.64M | $54.8K | $109.7K | $260.8K | $77.1K | $15.1K | - |
| Free cash flow | -$27.68M | -$18.21M | -$15.65M | -$12.65M | -$10.31M | -$6.02M | -$4.36M | -$1.89M | -$806.3K | - |
| Investing cash flow | -$3.93M | -$2.49M | -$1.70M | -$1.64M | -$54.8K | -$109.7K | -$260.8K | -$77.1K | -$15.3K | $0 |
| Financing cash flow | $21.53M | $22.08M | $21.09M | $7.37M | $17.92M | $4.36M | $924.0K | $4.14M | $4.71M | $0 |
| Share repurchases | - | - | - | - | - | - | - | - | $0 | - |
| Stock-based compensation | $1.78M | $2.38M | $2.70M | $2.72M | $4.03M | $1.23M | $801.2K | $532.1K | $0 | - |
| Depreciation and amortization | $1.67M | $1.06M | $426.0K | $152.0K | $117.5K | $111.0K | $35.4K | $14.5K | $1.9K | - |
Key ratios
| Line item | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Jun 30, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on equity | -217.9% | -110.2% | -151.5% | -273.4% | -210.8% | - | -184.9% | -39.2% | -15.3% | - |
| Return on assets | -190.4% | -100.5% | -126.5% | -191.6% | -189.2% | -328.2% | -137.9% | -38.2% | -15.2% | -1239.8% |
| Current ratio | 4.03 | 10.69 | 6.66 | 4.13 | 9.68 | 0.50 | 4.82 | 36.71 | 278.81 | 0.02 |
Income statement
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | $108.0K | - |
| Research and development | $4.37M | $3.84M | $5.41M | $5.59M | $5.13M | $3.94M | $3.85M | $3.70M | $3.21M | $3.12M | $3.84M | $3.16M |
| Selling, general and admin | $2.17M | $1.84M | $1.84M | $2.24M | $1.67M | $1.04M | $1.00M | $1.29M | $1.01M | $1.20M | $1.43M | $1.03M |
| Operating income | -$6.54M | -$5.68M | -$7.24M | -$7.83M | -$6.80M | -$4.98M | -$4.85M | -$5.00M | -$4.22M | -$4.32M | -$5.27M | -$4.19M |
| Pre-tax income | - | -$6.39M | -$7.36M | -$7.79M | -$6.70M | -$4.93M | -$4.80M | -$4.95M | -$4.14M | -$4.28M | -$5.27M | -$4.18M |
| Income tax | - | $0 | $0 | $2.0K | $0 | $0 | $0 | $2.0K | $0 | $0 | $0 | $2.0K |
| Net income | -$6.49M | -$6.39M | -$7.36M | -$7.79M | -$6.70M | -$4.93M | -$4.80M | -$4.96M | -$4.14M | -$4.28M | -$5.27M | -$4.18M |
| EPS, basic | -$1.19 | - | -$3.30 | -$4.20 | -$3.70 | -$3.56 | -$3.90 | -$4.20 | -$3.60 | - | -$6.90 | -$5.70 |
| EPS, diluted | -$1.19 | - | -$3.30 | -$4.20 | -$3.70 | -$3.56 | -$3.90 | -$4.20 | -$3.60 | - | -$6.90 | -$5.70 |
| Diluted shares | 5.5M | - | 2.2M | 1.9M | 1.8M | - | 1.3M | 1.1M | 1.1M | - | 751,333.333 | 748,166.667 |
Balance sheet
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $3.92M | $6.94M | $2.94M | $5.32M | $7.52M | $13.10M | $6.99M | $3.89M | $5.05M | $9.23M | $2.05M | $6.33M |
| Receivables | - | - | - | - | - | - | - | - | - | $142.0K | - | - |
| Current assets | $4.84M | $7.54M | $3.47M | $5.95M | $8.29M | $13.52M | $7.33M | $4.18M | $5.41M | $9.70M | $2.34M | $6.46M |
| Total assets | $12.25M | $14.83M | $10.26M | $12.97M | $14.17M | $18.73M | $12.15M | $8.77M | $10.07M | $13.81M | $6.20M | $10.06M |
| Current liabilities | $1.49M | $1.87M | $2.18M | $4.04M | $2.05M | $1.26M | $1.38M | $1.24M | $1.34M | $1.46M | $1.44M | $1.11M |
| Total liabilities | $1.49M | $1.87M | $4.38M | $4.21M | $2.33M | $1.66M | $1.89M | $1.85M | $2.06M | $2.27M | $2.35M | $2.12M |
| Shareholders' equity | $10.76M | $12.96M | $5.88M | $8.77M | $11.84M | $17.08M | $10.26M | $6.92M | $8.02M | $11.54M | $3.85M | $7.94M |
Cash flow
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$5.97M | -$5.82M | -$7.16M | -$5.41M | -$5.37M | -$4.31M | -$4.10M | -$3.77M | -$3.55M | -$3.50M | -$3.96M | -$3.28M |
| Capital expenditures | $688.0K | $1.00M | $1.22M | $771.0K | $934.0K | $948.0K | $542.0K | $161.0K | $842.0K | $483.0K | $499.0K | $345.0K |
| Free cash flow | -$6.66M | -$6.82M | -$8.38M | -$6.18M | -$6.31M | -$5.26M | -$4.64M | -$3.93M | -$4.39M | -$3.99M | -$4.46M | -$3.62M |
| Investing cash flow | -$688.0K | -$1.00M | -$1.22M | -$771.0K | -$934.0K | -$948.0K | -$542.0K | -$161.0K | -$842.0K | -$483.0K | -$499.0K | -$345.0K |
| Financing cash flow | $3.64M | $10.82M | $6.00M | $3.98M | $733.0K | $11.37M | $7.73M | $2.77M | $210.0K | $11.17M | $181.0K | $0 |
| Stock-based compensation | $447.0K | -$293.0K | $534.0K | $813.0K | $724.0K | $374.0K | $419.0K | $1.05M | $535.0K | $658.0K | $995.0K | $564.0K |
| Depreciation and amortization | $501.0K | $441.0K | $430.0K | $391.0K | $410.0K | $326.0K | $281.0K | $260.0K | $196.0K | $143.0K | $130.0K | $95.0K |
Key ratios
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | - | - | - | - | - | - | - | - | - | - | 170.0% | - |
| Operating margin | - | - | - | - | - | - | - | - | - | - | -4878.7% | - |
| Net margin | - | - | - | - | - | - | - | - | - | - | -4878.7% | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - | -4133.3% | - |
| Current ratio | 3.25 | 4.03 | 1.59 | 1.47 | 4.04 | 10.69 | 5.30 | 3.36 | 4.03 | 6.66 | 1.63 | 5.81 |
Source: XBRL data Modular Medical Inc. files with the SEC, latest filing dated Aug 14, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures and share counts are restated for stock splits the filings show: 1-for-3, first reported Feb 14, 2022; 1-for-30, first reported Jun 29, 2026.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
MODD peers
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| MODD | - | - | -$28.03M | - | $12.6M |
| SYK | $26.30B | +7.9% | $3.62B | 13.8% | $124.05B |
| MMM | $25.25B | +1.7% | $3.54B | 14.0% | $95.67B |
| BSX | $21.07B | +8.9% | $3.50B | 16.6% | $61.96B |
| BDX | $23.25B | +17.4% | $941.00M | 4.0% | $57.71B |
| MDLN | $30.68B | - | $683.00M | 2.2% | $52.13B |
| RMD | $5.73B | +9.0% | $1.59B | 27.8% | $33.10B |
| DXCM | $5.10B | +13.0% | $991.00M | 19.4% | $29.62B |
| WST | $3.40B | +12.6% | $638.90M | 18.8% | $27.85B |
MODD FAQ
5 questionsIs MODD profitable?
No. Modular Medical Inc. reported a net loss of $28.03M for the twelve months ended Jun 30, 2026.How much cash and debt does MODD have?
Modular Medical Inc. reported $3.92M in cash and cash equivalents on its most recent balance sheet in SEC filings.What is MODD free cash flow?
Modular Medical Inc. generated -$28.04M of free cash flow for the twelve months ended Jun 30, 2026, which is operating cash flow of -$24.35M less capital expenditures.When did MODD last report financial results?
The latest statements here come from Modular Medical Inc.'s 10-Q filed on Aug 14, 2026, covering the period ended Jun 30, 2026.Where does this MODD financial data come from?
Quantisnow builds these statements from the structured XBRL data Modular Medical Inc. files with the SEC. It is provided for information only and is not investment advice.